Frontiers in RAS Pathobiology and Drug Discovery


September 13-16, 2018, Stratton, VT

Organized by:

Sharon Campbell, Univ. of North Carolina;

Mark Philips, NYU School of Medicine

Keynote Speaker:

  • Robert Weinberg: Influence of Epigenetic Programs on Cancer Progression

Highlighted Speakers:

  • Frank McCormick
  • Kevin Haigis
  • Dafna Bar-Sagi
  • Kevan Shokat
  • David Scheinberg

Planned Sessions:

Topics selected to highlight the newest aspects of RAS biology and anti-RAS drug discovery include:

  • RAS Biochemistry, Cell Biology and Signaling
  • RAS and cancer; Animal Models
  • RAS, Metabolism, and Tumor Microenvironment
  • Anti-RAS Drug Development
  • RAS and Cancer Immunotherapy

The overarching goal of the meeting will be to bring scientists from a variety of backgrounds, from structural biology to cancer physiology, together to focus on the problem of RAS the oncogene using state-of-the-art tools with the hope of informing efforts at drug development.